[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341111-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341111-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","neddylation-of-insulin-receptor-substrate-acts-as-a-bona-fide-regulator-of-insulin-signaling-and-its-implications-for-cancer-cell-migration","Neddylation of insulin receptor substrate acts as a bona fide regulator of insulin signaling and its implications for cancer cell migration","","Irregular insulin signaling is linked to elevated cancer risk, yet the mechanisms driving this connection remain unclear. The study shows that inhibiting neddylation increases migration of cancer cells across cancer types by activating IRS1, IRS2, and the PI3K/AKT pathway. In high-grade serous carcinoma, IRS1/IRS2 correlate while inversely relating to NEDD8, and C-CBL is identified as an IRS1/IRS2 neddylating E3 ligase. Clinical data supports a reciprocal C-CBL–pAKT relationship, reinforcing C-CBL’s tumor-suppressive function. These results indicate neddylation modulates IRS-dependent insulin signaling and can restrain migration, suggesting caution with neddylation inhibitors in patients with insulin dysregulation from obesity-related T2DM or hyperinsulinemia.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/neddylation-of-insulin-receptor-substrate-acts-as-a-bona-fide-regulator-of-insulin-signaling-and-its-implications-for-cancer-cell-migration/341111/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/neddylation-of-insulin-receptor-substrate-acts-as-a-bona-fide-regulator-of-insulin-signaling-and-its-implications-for-cancer-cell-migration/341111.png","ImageObject",300,407,{"name":42,"@type":43},"Emma Wilson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does inhibiting neddylation affect cancer cell migration?","Question",{"text":63,"@type":64},"Inhibiting neddylation enhances cancer cell migration across different cancer types by activating IRS1 and IRS2 along with the PI3K/AKT pathway.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What relationship is observed between IRS1/IRS2, NEDD8, and high-grade serous carcinoma?",{"text":68,"@type":64},"In high-grade serous carcinoma patients, IRS1 and IRS2 show a parallel relationship with each other while exhibiting an inverse relationship with NEDD8, regardless of type 2 diabetes status.",{"name":70,"@type":61,"acceptedAnswer":71},"Which enzyme is identified as responsible for neddylating IRS1 and IRS2, and what is its clinical significance?",{"text":72,"@type":64},"C-CBL is identified as the E3 ligase that neddylates IRS1 and IRS2. Clinical evidence confirms a reciprocal relationship between C-CBL and pAKT, supporting a tumor-suppressive role for C-CBL.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341111,1790191121,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Cancer Gene [Therapy](Therapy www.nature.com/cgt)[ www.nature.com/cgt](Therapy www.nature.com/cgt)  \nARTICLE OPEN   \nNeddylation of insulin receptor substrate acts as a bona ﬁde regulator of insulin signaling and its implications for cancer cell migration  \nJun Bum Park1,2, Geon Ho Moon1,2, Ara Cho3, Minji Kwon4, Jong-Wan Park 1,2, Eugene C. Yi3, Haeryoung Kim4, Junji Fukuda5, Cheol Kwak6, Young-Gyu Ko 7 and Yang-Sook Chun 1,2,8 ✉  \n© The Author(s) 2024  \n|  |  |  |\n| --- | --- | --- |\n|  | Irregularities in insulin signaling have signiﬁcantly increased the risk of various cancers, yet the precise underlying mechanisms remain unclear. Within our study, we observed that inhibiting neddylation enhances cancer cell migration across different cancer types by activating both insulin receptor substrates 1 and 2 (IRS1 and IRS2), along with the PI3K/AKT signaling pathway. Notably, in the context of high-grade serous carcinoma (HGSC) patients, whether they had type 2 diabetes mellitus or not, IRS1 and IRS2 displayed a parallel relationship with each other while exhibiting an inverse relationship with NEDD8. We also identiﬁed C-CBL as an E3 ligase responsible for neddylating IRS1 and IRS2, with clinical evidence further conﬁrming a reciprocal relationship between C-CBL and pAKT, thereby reinforcing the tumor suppressive role of C-CBL. Altogether, these ﬁndings suggest that neddylation genuinely participates in IRS1 and IRS2-dependent insulin signaling, effectively suppressing cancer cell migration. Thus, caution is advised when considering neddylation inhibitors as a treatment option for cancer patients, particularly those presenting with |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| insulin signaling dysregulations linked to conditions like obesity-related type 2 diabetes or hyperinsulinemia. |  |  |\n|  | Cancer Gene Therapy (2024) 31:599–611; [https://doi.org/10.1038/s41417-024-00729-z](https://doi.org/10.1038/s41417-024-00729-z) |  |\n|  |  |  |\n\nINTRODUCTION  \nThe association between cancer and diabetes has garnered signiﬁcant attention in recent years due to their overlapping pathophysiological mechanisms and epidemiological connections. Epidemiological studies have consistently demonstrated an increased risk in a wide range of cancer types, including frequently reported cases such as pancreatic, colorectal, prostate, and ovarian cancers in type 2 diabetes mellitus (T2DM) patients as well as less studied cancers like renal, bladder, and brain cancer [1–7] . Insulin dysregulation is a key feature of type 2 diabetes that interferes with the insulin signaling pathways and has been identiﬁed as a risk factor for the development and progression of various types of cancer [8] .  \nInsulin receptor substrates 1 and 2 (IRS1 and IRS2) play pivotal roles in insulin signaling, acting as intermediaries that transmit insulin’s effects to cellular processes closely associated with cancer. Activation of IRS proteins occurs in cancer cells when insulin binds to the Insulin Receptor (IR), leading to a chain of intricate signaling cascades. IRS proteins are found at higher levels in human cancers compared to normal tissues, implying their potential involvement in tumorigenesis. Most cancer types also exhibit elevated expression levels of IRS proteins, hinting at the potential diverse and context-dependent roles of IRS proteins in cancer [9] .  \nUnderstanding the diverse mechanisms that activate IRS1 and IRS2 is crucial, calling for extensive research at the protein levels and beyond. Posttranslational modiﬁcations are currently being closely examined as a key factor in regulating the activities of IRS proteins and their interactions with downstream effectors. Notably, important modiﬁcations such as phosphorylation, ubiquitination, O-GlcNAcylation, and acetylation play critical roles in various cellular processes and disease states [10–14] . Studies have linked high blood sugar to abnormal fat","cbCaifu5vPfLa41N","https://ap.wps.com/l/cbCaifu5vPfLa41N","pdf",5405323,13,"English","# Introduction\n## Cancer–diabetes link and insulin dysregulation\n## IRS1/IRS2 roles and activation in cancer\n## Posttranslational modifications governing IRS proteins\n## Neddylation overview and study rationale","[{\"question\":\"How does inhibiting neddylation affect cancer cell migration?\",\"answer\":\"Inhibiting neddylation enhances cancer cell migration across different cancer types by activating IRS1 and IRS2 along with the PI3K/AKT pathway.\"},{\"question\":\"What relationship is observed between IRS1/IRS2, NEDD8, and high-grade serous carcinoma?\",\"answer\":\"In high-grade serous carcinoma patients, IRS1 and IRS2 show a parallel relationship with each other while exhibiting an inverse relationship with NEDD8, regardless of type 2 diabetes status.\"},{\"question\":\"Which enzyme is identified as responsible for neddylating IRS1 and IRS2, and what is its clinical significance?\",\"answer\":\"C-CBL is identified as the E3 ligase that neddylates IRS1 and IRS2. Clinical evidence confirms a reciprocal relationship between C-CBL and pAKT, supporting a tumor-suppressive role for C-CBL.\"}]","Neddylation of insulin receptor substrate acts as a bona fide regulator of insulin signaling and its implications for cancer cell migration | PDF",1790040373,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e150f19760a6c59adcc7a07d0855c4e3.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bca6cd8f4067f8565bd765d78e203805.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b785c322312020ef33dde898b9d562f1.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/deb95a31afcdc5a248d2460192af8428.webp",980,1301]